Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rosanna Lau, Min Ying Niu & M.A. Christine Pratt. (2012) cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation. Cell Cycle 11:21, pages 4009-4019.
Read now
Read now
Articles from other publishers (82)
David Carr, Aiman Zein, Josée Coulombe, Tianqi Jiang, Miguel A. Cabrita, Gwendoline Ward, Manijeh Daneshmand, Andrea Sau & M. A. Christine Pratt. (2022) Multiple roles for Bcl-3 in mammary gland branching, stromal collagen invasion, involution and tumor pathology. Breast Cancer Research 24:1.
Crossref
Crossref
Inês Soares de Pinho, Catarina Abreu, Inês Gomes, Sandra Casimiro, Teresa Raquel Pacheco, Rita Teixeira de Sousa & Luís Costa. (2022) Exploring new pathways in endocrine-resistant breast cancer. Exploration of Targeted Anti-tumor Therapy, pages 337-361.
Crossref
Crossref
Svetlana E. Semina, Purab Pal, Nidhi S. Kansara, Rosemary J. Huggins, Elaine T. Alarid, Geoffrey L. Greene & Jonna Frasor. (2022) Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells. Breast Cancer Research 24:1.
Crossref
Crossref
Piotr Czapiewski, Maximilian Cornelius, Roland Hartig, Thomas Kalinski, Johannes Haybaeck, Angela Dittmer, Jürgen Dittmer, Atanas Ignatov & Norbert Nass. (2022) BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study. Virchows Archiv 480:3, pages 529-541.
Crossref
Crossref
Daniela Hühn, Pablo Martí‐Rodrigo, Silvana Mouron, Catherine Hansel, Kirsten Tschapalda, Bartlomiej Porebski, Maria Häggblad, Louise Lidemalm, Miguel Quintela‐Fandino, Jordi Carreras‐Puigvert & Oscar Fernandez‐Capetillo. (2021) Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells. Molecular Oncology 16:1, pages 148-165.
Crossref
Crossref
Chandra K. Maharjan, Jiao Mo, Lei Wang, Myung-Chul Kim, Sameul Wang, Nicholas Borcherding, Praveen Vikas & Weizhou Zhang. (2021) Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer. Cancers 14:1, pages 206.
Crossref
Crossref
Daniel J Turnham, William W Yang, Julia Davies, Athina Varnava, Anne J Ridley, R Steven Conlan & Richard W E Clarkson. (2020) Bcl-3 promotes multi-modal tumour cell migration via NF-κB1 mediated regulation of Cdc42. Carcinogenesis 41:10, pages 1432-1443.
Crossref
Crossref
Xiumei Wang, Yao Fang, Wenbo Sun, Zhi Xu, Yanyan Zhang, Xiaowei Wei, Xuansheng Ding & Yong Xu. (2020) Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review). International Journal of Oncology.
Crossref
Crossref
Angela Dittmer, Theresia Lange, Benjamin Leyh & J�rgen Dittmer. (2019) Protein‑ and growth‑modulatory effects of carcinoma‑associated fibroblasts on breast cancer cells: Role of interleukin‑6. International Journal of Oncology.
Crossref
Crossref
Aradhana Rani, Justin Stebbing, Georgios Giamas & John Murphy. (2019) Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy. Frontiers in Endocrinology 10.
Crossref
Crossref
Robert Clarke. 2019. The Unfolded Protein Response in Cancer. The Unfolded Protein Response in Cancer
163
180
.
David Carr, Rosanna Lau, Alexandra D. Hnatykiw, Gwendoline C. D. Ward, Manijeh Daneshmand, Miguel A. Cabrita & M. A. Christine Pratt. (2018) cIAP2 Is an Independent Signaling and Survival Factor during Mammary Lactational Involution and Tumorigenesis. Journal of Mammary Gland Biology and Neoplasia 23:3, pages 109-123.
Crossref
Crossref
Fatma Ashour, Mohammed H. Awwad, Hayam E.L. Sharawy & Mohamed Kamal. (2018) Estrogen receptor positive breast tumors resist chemotherapy by the overexpression of P53 in Cancer Stem Cells. Journal of the Egyptian National Cancer Institute 30:2, pages 45-48.
Crossref
Crossref
Andrea Sau, Miguel A. Cabrita & M.A. Christine Pratt. (2018)
NF-κB at the Crossroads of Normal Mammary Gland Biology and the Pathogenesis and Prevention of
BRCA1
-Mutated Breast Cancer
. Cancer Prevention Research 11:2, pages 69-80.
Crossref
Crossref
Xi Chen, Xinwei Cao, Xiaohua Sun, Rong Lei, Pengfei Chen, Yongxu Zhao, Yuhang Jiang, Jie Yin, Ran Chen, Deji Ye, Qi Wang, Zhanjie Liu, Sanhong Liu, Chunyan Cheng, Jie Mao, Yingyong Hou, Mingliang Wang, Ulrich Siebenlist, Y Eugene Chin, Ying Wang, Liu Cao, Guohong Hu & Xiaoren Zhang. (2016) Bcl-3 regulates TGFβ signaling by stabilizing Smad3 during breast cancer pulmonary metastasis. Cell Death & Disease 7:12, pages e2508-e2508.
Crossref
Crossref
Benjamin Leyh, Angela Dittmer, Theresia Lange, John W. M. Martens & Jürgen Dittmer. (2015) Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis. Oncotarget 6:36, pages 39307-39328.
Crossref
Crossref
Foteinos-Ioannis D. Dimitrakopoulos, Anna G. Antonacopoulou, Anastasia Kottorou, Stella Marousi, Ioulia Koukourikou, Melpomeni Kalofonou, Nikolaos Panagopoulos, Chrisoula Scopa, Dimitrios Dougenis, Helen Papadaki, Athanasios G. Papavassiliou & Haralabos P. Kalofonos. (2015) Variant of BCL3 gene is strongly associated with five-year survival of non-small-cell lung cancer patients. Lung Cancer 89:3, pages 311-319.
Crossref
Crossref
Durkeshwari Anbalagan, Gracemary Yap, Yi Yuan, Vijay K. Pandey, Wai Hoe Lau, Suruchi Arora, Pradeep Bist, Justin S. B. Wong, Gautam Sethi, Peter M. Nissom, Peter E. Lobie & Lina H. K. Lim. (2014) Annexin-A1 Regulates MicroRNA-26b* and MicroRNA-562 to Directly Target NF-κB and Angiogenesis in Breast Cancer Cells. PLoS ONE 9:12, pages e114507.
Crossref
Crossref
Jennifer R. Ribeiro & Richard N. Freiman. (2014) Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer. The Journal of Steroid Biochemistry and Molecular Biology 143, pages 160-173.
Crossref
Crossref
Lacey M. Litchfield, Savitri N. Appana, Susmita Datta & Carolyn M. Klinge. (2014) COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells. Molecular and Cellular Endocrinology 382:1, pages 358-367.
Crossref
Crossref
Chun Chen, William T. Baumann, Robert Clarke & John J. Tyson. (2013) Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cells. FEBS Letters 587:20, pages 3327-3334.
Crossref
Crossref
Jinghua Gu, Jianhua Xuan, Xiao Wang, Ayesha N. Shajahan, Leena Hilakivi-Clarke & Robert Clarke. (2013) Reconstructing transcriptional regulatory networks by probabilistic network component analysis. Reconstructing transcriptional regulatory networks by probabilistic network component analysis.
Alison Wakefield, Jitka Soukupova, Amelie Montagne, Jill Ranger, Rhiannon French, William J. Muller & Richard W. E. Clarkson. (2013) Bcl3 Selectively Promotes Metastasis of ERBB2-Driven Mammary Tumors. Cancer Research 73:2, pages 745-755.
Crossref
Crossref
Kuo-Sheng Hsu & Hung-Ying Kao. 2013. Hormones and Breast Cancer. Hormones and Breast Cancer
323
351
.
Jinghua Gu, Jianhua Xuan, Rebecca B. Riggins, Li Chen, Yue Wang & Robert Clarke. (2012) Robust identification of transcriptional regulatory networks using a Gibbs sampler on outlier sum statistic. Bioinformatics 28:15, pages 1990-1997.
Crossref
Crossref
Eunice López-Muñoz, Adelina Hernández-Zarco, Normand García-Hernández, Isabel Alvarado-Cabrero, Gelasio Zarco-Espinosa, Fabio Salamanca-Gómez & Diego Arenas-Aranda. (2012) BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients. Clinical and Translational Oncology 14:8, pages 586-591.
Crossref
Crossref
Lobna MKAOUAR, Yoshifumi ENDO, He Xi JUN, Soo-Jung LEE, Tassanee JAROENSONG, Manabu MOCHIZUKI, Kazuyuki UCHIDA, Hiroyuki NAKAYAMA, Nobuo SASAKI & Takayuki NAKAGAWA. (2012) Relationship between NF-κB Expression and Malignancy of Canine Mammary Gland Tumor Tissues. Journal of Veterinary Medical Science 74:6, pages 713-718.
Crossref
Crossref
Tetsuo Mitsui, Maho Ishida, Michi Izawa, Yoshihiro Kagami & Jun Arita. (2011) Inhibition of Bcl3 gene expression mediates the anti-proliferative action of estrogen in pituitary lactotrophs in primary culture. Molecular and Cellular Endocrinology 345:1-2, pages 68-78.
Crossref
Crossref
Shuet Theng Lee, Zhimei Li, Zhenlong Wu, Meiyee Aau, Peiyong Guan, R.K. Murthy Karuturi, Yih Cherng Liou & Qiang Yu. (2011) Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers. Molecular Cell 43:5, pages 798-810.
Crossref
Crossref
John J. Tyson, William T. Baumann, Chun Chen, Anael Verdugo, Iman Tavassoly, Yue Wang, Louis M. Weiner & Robert Clarke. (2011) Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells. Nature Reviews Cancer 11:7, pages 523-532.
Crossref
Crossref
Marco A. Velasco-Velázquez, Vladimir M. Popov, Michael P. Lisanti & Richard G. Pestell. (2011) The Role of Breast Cancer Stem Cells in Metastasis and Therapeutic Implications. The American Journal of Pathology 179:1, pages 2-11.
Crossref
Crossref
Marco A Velasco-Velázquez, Zhiping Li, Mathew Casimiro, Emanuele Loro, Nora Homsi & Richard G Pestell. (2011) Examining the role of cyclin D1 in breast cancer. Future Oncology 7:6, pages 753-765.
Crossref
Crossref
Dagmar García-Rivera, René Delgado, Nadia Bougarne, Guy Haegeman & Wim Vanden Berghe. (2011) Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells. Cancer Letters 305:1, pages 21-31.
Crossref
Crossref
Yuki Ishii, Luena Papa, Urvashi Bahadur, Zhenyu Yue, Julio Aguirre-Ghiso, Toshi Shioda, Samuel Waxman & Doris Germain. (2011) Bortezomib Enhances the Efficacy of Fulvestrant by Amplifying the Aggregation of the Estrogen Receptor, Which Leads to a Proapoptotic Unfolded Protein Response. Clinical Cancer Research 17:8, pages 2292-2300.
Crossref
Crossref
Robert Clarke, Ayesha N. Shajahan, Yue Wang, John J. Tyson, Rebecca B. Riggins, Louis M. Weiner, William T. Bauman, Jianhua Xuan, Bai Zhang, Caroline Facey, Harini Aiyer, Katherine Cook, F. Edward Hickman, Iman Tavassoly, Anael Verdugo, Chun Chen, Alan Zwart, Anni Wärri & Leena A. Hilakivi-Clarke. (2011) Endoplasmic reticulum stress, the unfolded protein response, and gene network modeling in antiestrogen resistant breast cancer. Hormone Molecular Biology and Clinical Investigation 5:1.
Crossref
Crossref
Vilma Maldonado & Jorge Melendez-Zajgla. (2011) Role of Bcl-3 in solid tumors. Molecular Cancer 10:1, pages 152.
Crossref
Crossref
Ruchi Nehra, Rebecca B. Riggins, Ayesha N. Shajahan, Alan Zwart, Anatasha C. Crawford & Robert Clarke. (2010) BCL2 and CASP8 regulation by NF‐κB differentially affect mitochondrial function and cell fate in antiestrogen‐sensitive and ‐resistant breast cancer cells. The FASEB Journal 24:6, pages 2040-2055.
Crossref
Crossref
Li Chen, Jianhua Xuan, Rebecca B. Riggins, Yue Wang, Eric P. Hoffman & Robert Clarke. (2010) Multilevel support vector regression analysis to identify condition-specific regulatory networks. Bioinformatics 26:11, pages 1416-1422.
Crossref
Crossref
Yanxia Ning, Rebecca B. Riggins, Jennifer E. Mulla, Haniee Chung, Alan Zwart & Robert Clarke. (2010) IFNγ Restores Breast Cancer Sensitivity to Fulvestrant by Regulating STAT1, IFN Regulatory Factor 1, NF-κB, BCL2 Family Members, and Signaling to Caspase-Dependent Apoptosis. Molecular Cancer Therapeutics 9:5, pages 1274-1285.
Crossref
Crossref
Bai Zhang, Huai Li, Robert Clarke, Leena Hilakivi-Clarke & Yue Wang. 2010. Medical Biostatistics for Complex Diseases. Medical Biostatistics for Complex Diseases
185
203
.
Jieying Zhao, Guangchun Chen, Dongmei Cao, Yidong Li, Fei Diao, Haoyu Cai, Yiduo Jin & Jian Lu. (2009) Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growth. Breast Cancer Research and Treatment 119:1, pages 39-51.
Crossref
Crossref
Ilse M. E. Beck, Guy Haegeman & Karolien De Bosscher. 2010. From Molecular to Modular Tumor Therapy. From Molecular to Modular Tumor Therapy
191
242
.
Shafiq Uddin Ahmed & Jo Milner. (2009) Basal Cancer Cell Survival Involves JNK2 Suppression of a Novel JNK1/c-Jun/Bcl-3 Apoptotic Network. PLoS ONE 4:10, pages e7305.
Crossref
Crossref
M A C Pratt, E Tibbo, S J Robertson, D Jansson, K Hurst, C Perez-Iratxeta, R Lau & M Y Niu. (2009) The canonical NF-κB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population. Oncogene 28:30, pages 2710-2722.
Crossref
Crossref
Nathalie Gionet, Deidre Jansson, Sylvie Mader & M.A. Christine Pratt. (2009) NF-κB and estrogen receptor α interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells. Journal of Cellular Biochemistry 107:3, pages 448-459.
Crossref
Crossref
Manran Liu, Xiaoming Ju, Nicole E. Willmarth, Mathew C. Casimiro, John Ojeifo, Toshiyuki Sakamaki, Sanjay Katiyar, Xuanmao Jiao, Vladimir M. Popov, Zuoren Yu, Kongming Wu, David Joyce, Chenguang Wang & Richard G. Pestell. (2009) Nuclear Factor-κB Enhances ErbB2-Induced Mammary Tumorigenesis and Neoangiogenesis in Vivo. The American Journal of Pathology 174:5, pages 1910-1920.
Crossref
Crossref
Angela Maselli, Paola Matarrese, Elisabetta Straface, Silvia Canu, Flavia Franconi & Walter Malorni. (2008) Cell sex: a new look at cell fate studies. The FASEB Journal 23:4, pages 978-984.
Crossref
Crossref
Robert Clarke, Ayesha N. Shajahan, Rebecca B. Riggins, Younsook Cho, Anatasha Crawford, Jianhua Xuan, Yue Wang, Alan Zwart, Ruchi Nehra & Minetta C. Liu. (2009) Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 114:1-2, pages 8-20.
Crossref
Crossref
Bai Zhang, Huai Li, Rebecca B. Riggins, Ming Zhan, Jianhua Xuan, Zhen Zhang, Eric P. Hoffman, Robert Clarke & Yue Wang. (2009) Differential dependency network analysis to identify condition-specific topological changes in biological networks. Bioinformatics 25:4, pages 526-532.
Crossref
Crossref
S J Veuger, J E Hunter & B W Durkacz. (2008) Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance. Oncogene 28:6, pages 832-842.
Crossref
Crossref
Ali Naderi & Luke Hughes-Davies. (2008) Nerve growth factor/nuclear factor-κB pathway as a therapeutic target in breast cancer. Journal of Cancer Research and Clinical Oncology 135:2, pages 211-216.
Crossref
Crossref
Julia M.W. Gee, Andrew Stone, Richard A. McClelland, Stephen Hiscox, Iain R. Hutcheson, Nicola J. Jordan, Heidi M. Fiegl, Martin Widschwendter, Victoria E. Shaw, Denise Barrow & Robert I. Nicholson. 2009. Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer. Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer
63
84
.
Ikuko Kijima, Jingjing Ye, Carlotta Glackin & Shiuan Chen. (2008) CCAAT/Enhancer Binding Protein δ Up-regulates Aromatase Promoters I.3/II in Breast Cancer Epithelial Cells. Cancer Research 68:11, pages 4455-4464.
Crossref
Crossref
Kelly J. Higgins, Shengxi Liu, Maen Abdelrahim, Kathryn Vanderlaag, Xinyi Liu, Weston Porter, Richard Metz & Stephen Safe. (2008) Vascular Endothelial Growth Factor Receptor-2 Expression Is Down-Regulated by 17β-Estradiol in MCF-7 Breast Cancer Cells by Estrogen Receptor α/Sp Proteins. Molecular Endocrinology 22:2, pages 388-402.
Crossref
Crossref
Steve Braunstein, Silvia C. Formenti & Robert J. Schneider. (2008) Acquisition of Stable Inducible Up-Regulation of Nuclear Factor-κB by Tumor Necrosis Factor Exposure Confers Increased Radiation Resistance without Increased Transformation in Breast Cancer Cells. Molecular Cancer Research 6:1, pages 78-88.
Crossref
Crossref
Roberto Gambari. 2008. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
175
187
.
Yamei Zhou, Christina Yau, Joe W Gray, Karen Chew, Shanaz H Dairkee, Dan H Moore, Urs Eppenberger, Serenella Eppenberger-Castori & Christopher C Benz. (2007) Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer. BMC Cancer 7:1.
Crossref
Crossref
Bianca P. Gomez, Rebecca B. Riggins, Ayesha N. Shajahan, Uwe Klimach, Aifen Wang, Anatasha C. Crawford, Yuelin Zhu, Alan Zwart, Mingyue Wang & Robert Clarke. (2007) Human X‐Box binding protein‐1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. The FASEB Journal 21:14, pages 4013-4027.
Crossref
Crossref
R. I. Nicholson, I. R. Hutcheson, H. E. Jones, S. E. Hiscox, M. Giles, K. M. Taylor & J. M. W. Gee. (2007) Growth factor signalling in endocrine and anti-growth factor resistant breast cancer. Reviews in Endocrine and Metabolic Disorders 8:3, pages 241-253.
Crossref
Crossref
S J Van Laere, I Van der Auwera, G G Van den Eynden, P van Dam, E A Van Marck, P B Vermeulen & L Y Dirix. (2007) NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. British Journal of Cancer 97:5, pages 659-669.
Crossref
Crossref
Ali Naderi, Andrew E. Teschendorff, Juergen Beigel, Massimiliano Cariati, Ian O. Ellis, James D. Brenton & Carlos Caldas. (2007)
BEX2
Is Overexpressed in a Subset of Primary Breast Cancers and Mediates Nerve Growth Factor/Nuclear Factor-κB Inhibition of Apoptosis in Breast Cancer Cell Lines
. Cancer Research 67:14, pages 6725-6736.
Crossref
Crossref
Amy M. Trauernicht, Se Jin Kim, Nam Hee Kim & Thomas G. Boyer. (2007) Modulation of Estrogen Receptor α Protein Level and Survival Function by DBC-1. Molecular Endocrinology 21:7, pages 1526-1536.
Crossref
Crossref
Suzue Hirano, Daisuke Furutama & Toshiaki Hanafusa. (2007) Physiologically high concentrations of 17β-estradiol enhance NF-κB activity in human T cells. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 292:4, pages R1465-R1471.
Crossref
Crossref
Yu. S. Lobanova, A. M. Scherbakov, V. A. Shatskaya & M. A. Krasil’nikov. (2007) Mechanism of estrogen-induced apoptosis in breast cancer cells: Role of the NF-κB signaling pathway. Biochemistry (Moscow) 72:3, pages 320-327.
Crossref
Crossref
Saurabh Gupta, Suneet Mehrotra, Carlos M. Villalón, Mercedes Perusquía, Pramod R. Saxena & Antoinette MaassenVanDenBrink. (2007) Potential role of female sex hormones in the pathophysiology of migraine. Pharmacology & Therapeutics 113:2, pages 321-340.
Crossref
Crossref
Jiping Zhang, Mary Ann Warren, Suzanne F. Shoemaker & Margot M. Ip. (2007) NFκB1/p50 Is Not Required for Tumor Necrosis Factor-Stimulated Growth of Primary Mammary Epithelial Cells: Implications for NFκB2/p52 and RelB. Endocrinology 148:1, pages 268-278.
Crossref
Crossref
K De Bosscher, W Vanden Berghe & G Haegeman. (2006) Cross-talk between nuclear receptors and nuclear factor κB. Oncogene 25:51, pages 6868-6886.
Crossref
Crossref
Steven J. Van Laere, Ilse Van der Auwera, Gert G. Van den Eynden, Hilde J. Elst, Joost Weyler, Adrian L. Harris, Peter van Dam, Eric A. Van Marck, Peter B. Vermeulen & Luc Y. Dirix. (2006) Nuclear Factor-κB Signature of Inflammatory Breast Cancer by cDNA Microarray Validated by Quantitative Real-time Reverse Transcription-PCR, Immunohistochemistry, and Nuclear Factor-κB DNA-Binding. Clinical Cancer Research 12:11, pages 3249-3256.
Crossref
Crossref
M F Rubio, S Werbajh, E G A Cafferata, A Quaglino, G P Coló, I M Nojek, E C Kordon, V E Nahmod & M A Costas. (2005) TNF-α enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Oncogene 25:9, pages 1367-1377.
Crossref
Crossref
Linsong Yang, Yali Hu & Yayi Hou. (2006) Effects of 17β-estradiol on the maturation, nuclear factor kappa B p65 and functions of murine spleen CD11c-positive dendritic cells. Molecular Immunology 43:4, pages 357-366.
Crossref
Crossref
Pei Yen Yeh, Sung-Hsin Kuo, Kun-Huei Yeh, Shuang-En Chuang, Chih-Hung Hsu, Wen Ching Chang, Hsin-I Lin, Ming Gao & Ann-Lii Cheng. (2006) A Pathway for Tumor Necrosis Factor-α-induced Bcl10 Nuclear Translocation. Journal of Biological Chemistry 281:1, pages 167-175.
Crossref
Crossref
Michael C. Haffner, Chiara Berlato & Wolfgang Doppler. (2006) Exploiting Our Knowledge of NF-κB Signaling for the Treatment of Mammary Cancer. Journal of Mammary Gland Biology and Neoplasia 11:1, pages 63-73.
Crossref
Crossref
Amanda M. de Mestre, Sudha Rao, June R. Hornby, Thura Soe-Htwe, Levon M. Khachigian & Mark D. Hulett. (2005) Early Growth Response Gene 1 (EGR1) Regulates Heparanase Gene Transcription in Tumor Cells. Journal of Biological Chemistry 280:42, pages 35136-35147.
Crossref
Crossref
Yamei Zhou, Serenella Eppenberger-Castori, Corina Marx, Christina Yau, Gary K. Scott, Urs Eppenberger & Christopher C. Benz. (2005) Activation of nuclear factor-κB (NFκB) identifies a high-risk subset of hormone-dependent breast cancers. The International Journal of Biochemistry & Cell Biology 37:5, pages 1130-1144.
Crossref
Crossref
Demetrios Kalaitzidis & Thomas D. Gilmore. (2005) Transcription factor cross-talk: the estrogen receptor and NF-κB. Trends in Endocrinology & Metabolism 16:2, pages 46-52.
Crossref
Crossref
José Antonio MUÑOZ-GÁMEZ, David MARTÍN-OLIVA, Rocío AGUILAR-QUESADA, Ana CAÑUELO, M. Isabel NUÑEZ, M. Teresa VALENZUELA, J. M. RUIZ de ALMODÓVAR, Gilbert de MURCIA & F. Javier OLIVER. (2005) PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Biochemical Journal 386:1, pages 119-125.
Crossref
Crossref
Rebecca B. Riggins, Alan Zwart, Ruchi Nehra & Robert Clarke. (2005) The nuclear factor κB inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)–induced apoptosis in antiestrogen-resistant breast cancer cells. Molecular Cancer Therapeutics 4:1, pages 33-41.
Crossref
Crossref
Rebecca B. Riggins, Amy H. Bouton, Minetta C. Liu & Robert Clarke. 2005.
201
237
.
Ethan D Emberley, Leigh C Murphy & Peter H Watson. (2004) S100A7 and the progression of breast cancer. Breast Cancer Research 6:4.
Crossref
Crossref
Kerrie B. Bouker, Todd C. Skaar, David R. Fernandez, Kerry A. O’Brien, Rebecca B. Riggins, Donghua Cao & Robert Clarke. (2004) Interferon Regulatory Factor-1 Mediates the Proapoptotic but Not Cell Cycle Arrest Effects of the Steroidal Antiestrogen ICI 182,780 (Faslodex, Fulvestrant). Cancer Research 64:11, pages 4030-4039.
Crossref
Crossref
Ming-Tsan Lin, Cheng-Chi Chang, Szu-Ta Chen, Huei-Ling Chang, Jen-Liang Su, Yat-Pang Chau & Min-Liang Kuo. (2004) Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-κB-dependent XIAP Up-Regulation. Journal of Biological Chemistry 279:23, pages 24015-24023.
Crossref
Crossref
Jingyung Hur, Jessica Chesnes, Kathryn R. Coser, Roseanna S. Lee, Peter Geck, Kurt J. Isselbacher & Toshi Shioda. (2004) The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis. Proceedings of the National Academy of Sciences 101:8, pages 2351-2356.
Crossref
Crossref